These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25840630)

  • 21. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE; Figliomeni M; Spector S
    Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obtaining optimal control in mild asthma: theory and practice.
    Watson L; Kerstjens HA; Rabe KF; Kiri V; Visick GT; Postma DS
    Fam Pract; 2005 Jun; 22(3):305-10. PubMed ID: 15805133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APPaRENT 3: Asthma Patients' and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries.
    Aggarwal B; Al-Moamary M; Allehebi R; Alzaabi A; Al-Ahmad M; Amin M; Damayanti T; Van Tho N; Quyen PTL; Sriprasart T; Poachanukoon O; Yu-Lin AB; Ismail AI; Limpin MEB; Koenig S; Levy G; Phansalkar A; Rafih F; Silvey M; Miriams L; Milligan G
    Adv Ther; 2024 Aug; 41(8):3089-3118. PubMed ID: 38874879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
    Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
    Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of bronchial asthma.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):217-20. PubMed ID: 11552671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
    CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications.
    Herborg H; Soendergaard B; Jorgensen T; Fonnesbaek L; Hepler CD; Holst H; Froekjaer B
    J Am Pharm Assoc (Wash); 2001; 41(4):551-9. PubMed ID: 11486981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroid-sparing options in the treatment of childhood asthma.
    Helms PJ
    Drugs; 2000; 59 Suppl 1():15-22; discussion 43-5. PubMed ID: 10741878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Asthma exacerbations: pharmacological prevention].
    Grassin-Delyle S; Girodet PO
    Rev Mal Respir; 2012 Feb; 29(2):232-44. PubMed ID: 22405116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient management of bronchial asthma in adults.
    Rosa JD; Chandy D; Aronow WS; DeLorenzo LJ
    Compr Ther; 2008; 34(1):10-7. PubMed ID: 18681106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of asthma among patients adherent to ICS/LABA: A real-world study.
    Davis J; Trudo F; Siddall J; Small M
    J Asthma; 2019 Mar; 56(3):332-340. PubMed ID: 29624458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost considerations of therapeutic options for children with asthma.
    Chuang S; Jaffe A
    Paediatr Drugs; 2012 Aug; 14(4):211-20. PubMed ID: 22642813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term management of asthma in children: effectiveness of inhaled corticosteroids compared to other medications.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S147-60. PubMed ID: 12518556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.